EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of vancomycin AUC24 monitoring using peak and trough concentrations in pediatric patients: a prospective multicenter study

Majed H Nahari, Abdullah Alsultan, Renad A Alshuraim, Abdullah Altuwayjiri, Sultan Alotaibi, Majed Aljeraisy

Frontiers in Pharmacology · 07.04.2026 · 17

DOI: 10.3389/fphar.2026.1790042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.04.2026. Verfasst von Majed H Nahari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Services, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah International Medical Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vancomycin remains a key medication in treating infections in pediatric patients, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). Conventional trough-based monitoring has shown limited accuracy in predicting therapeutic exposure and nephrotoxicity. Recent guidelines recommend area under the concentration–time curve (AUC)-based monitoring, but pediatric evidence remains scarce. Our objective is to assess the feasibility of vancomycin AUC 24 monitoring using peak–trough concentrations in routine pediatric clinical practice and examine its correlation with the trough levels.

Methods

We conducted a prospective, multicenter study in 70 pediatric inpatients receiving vancomycin at two tertiary hospitals in Riyadh, Saudi Arabia. Vancomycin AUC 24 was calculated using first-order pharmacokinetics from peak and trough levels. AUC 24 was compared with the trough concentrations and dosing regimens.

Results

Implementation of AUC 24 -based monitoring was feasible in routine pediatric workflow. Pharmacists successfully calculated AUC 24 using the Sanford Guide mobile app, with minimal training required for nurses on sampling. The correlation between the trough levels and AUC 24 was strong (ρ = 0.789, p < 0.001), but the trough values did not consistently predict target attainment (AUC 24 400 μg h/mL–600 μg h/mL). At trough concentrations of 10 μg/mL–15 μg/mL, only approximately half of the patients achieved the target AUC 24 range (400 μg h/mL–600 μg h/mL), whereas at troughs of 15 μg/mL–20 μg/mL, nearly half of the patients exceeded the safe exposure thresholds, underscoring the limitations of trough-based monitoring.

Conclusion

AUC 24 estimation from peak and trough samples was feasible in routine pediatric workflow, providing more accurate exposure assessment than trough-guided monitoring. Implementation may improve efficacy and minimize nephrotoxicity.

Schlagwörter

Stichwörter der Autor:innen

AUC-guided dosingarea under the curve (AUC)feasibility studypediatric pharmacokineticstherapeutic drug monitoringvancomycin

Autor:innen und Institutionen

  • Pharmaceutical Care Services, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
  • Collage of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Pharmaceutical Care Services, King Saud Medical City, Riyadh, Saudi Arabia.
  • Pharmaceutical Care Services, King Salman Specialized Hospital, Taif, Saudi Arabia.
  • King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Förderung

  • King Abdullah International Medical Research Center

Zitieren

APA

Nahari, M. H., Alsultan, A., Alshuraim, R. A., Altuwayjiri, A., Alotaibi, S., & Aljeraisy, M. (2026). Feasibility of vancomycin AUC24 monitoring using peak and trough concentrations in pediatric patients: a prospective multicenter study. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1790042

Vancouver

Nahari MH, Alsultan A, Alshuraim RA, Altuwayjiri A, Alotaibi S, Aljeraisy M. Feasibility of vancomycin AUC24 monitoring using peak and trough concentrations in pediatric patients: a prospective multicenter study. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1790042

BibTeX
@article{Nahari2026,
  author = {Nahari, Majed H and Alsultan, Abdullah and Alshuraim, Renad A and Altuwayjiri, Abdullah and Alotaibi, Sultan and Aljeraisy, Majed},
  title = {Feasibility of vancomycin AUC24 monitoring using peak and trough concentrations in pediatric patients: a prospective multicenter study},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1790042}
}
Kostenlos starten →